Wealth and Asset Management
Mesoblast moves to tap private wealth funds
Regenerative medicine company Mesoblast has tapped into a fresh vein of capital, this time some of Melbourne's high net worth families who have agreed to invest up to $120 million via David Lamm's from Kentgrove Capital, which handles funds of the Alter family along with other investors. Mesoblast incurred investor…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: The Sydney Morning Herald